Potential Utility of Pre-Emptive Germline Pharmacogenetics in Breast Cancer

SIMPLE SUMMARY: Breast cancer outcomes are variable due to differences in tumor biology, patient biology, and treatment. The likelihood of developing cancer and other diseases increases with age. Thus, many patients with breast cancer have multiple co-morbidities requiring medical management, which...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernard, Philip S., Wooderchak-Donahue, Whitney, Wei, Mei, Bray, Steven M., Wood, Kevin C., Parikh, Baiju, McMillin, Gwendolyn A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998388/
https://www.ncbi.nlm.nih.gov/pubmed/33799547
http://dx.doi.org/10.3390/cancers13061219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998388/
https://www.ncbi.nlm.nih.gov/pubmed/33799547
http://dx.doi.org/10.3390/cancers13061219

Ejemplares similares